Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Rooney

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Vox Sanguinis|August 15, 1998
Gene and cell transfer for specific immunotherapyM K Brenner, H E Heslop, C M Rooney
Blood Reviews|December 1, 1995
Gene-marking and haemopoietic stem-cell transplantationH E Heslop, C M Rooney, M K Brenner
The New England Journal of Medicine|September 8, 1994
Donor T cells to treat EBV-associated lymphomaH E Heslop, M K Brenner, C M Rooney
Vox Sanguinis|August 15, 1998
EBV specific CTL: a model for immune therapyC M Rooney, H E Heslop, M K Brenner
Infection Prevention in Practice|July 28, 2021
Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2C M Rooney, J McIntyre, L Ritchie, et al.
The Journal of Infectious Diseases|December 12, 1997
Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infectionJ E Tanner, F Diaz-Mitoma, C M Rooney, et al.
Journal of Virology|July 1, 1989
The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycleC M Rooney, D T Rowe, T Ragot, et al.
Nature|October 17, 1985
Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillanceC M Rooney, M Rowe, L E Wallace, et al.
The EMBO Journal|January 1, 1989
Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fosP J Farrell, D T Rowe, C M Rooney, et al.
Cytotherapy|July 10, 2003
Suicide genes as safety switches in T lymphocytesK C Straathof, D M Spencer, R E Sutton, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Vox Sanguinis|August 15, 1998
Gene and cell transfer for specific immunotherapyM K Brenner, H E Heslop, C M Rooney
Blood Reviews|December 1, 1995
Gene-marking and haemopoietic stem-cell transplantationH E Heslop, C M Rooney, M K Brenner
The New England Journal of Medicine|September 8, 1994
Donor T cells to treat EBV-associated lymphomaH E Heslop, M K Brenner, C M Rooney
Vox Sanguinis|August 15, 1998
EBV specific CTL: a model for immune therapyC M Rooney, H E Heslop, M K Brenner
Infection Prevention in Practice|July 28, 2021
Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2C M Rooney, J McIntyre, L Ritchie, et al.
The Journal of Infectious Diseases|December 12, 1997
Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infectionJ E Tanner, F Diaz-Mitoma, C M Rooney, et al.
Journal of Virology|July 1, 1989
The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycleC M Rooney, D T Rowe, T Ragot, et al.
Nature|October 17, 1985
Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillanceC M Rooney, M Rowe, L E Wallace, et al.
The EMBO Journal|January 1, 1989
Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fosP J Farrell, D T Rowe, C M Rooney, et al.
Cytotherapy|July 10, 2003
Suicide genes as safety switches in T lymphocytesK C Straathof, D M Spencer, R E Sutton, et al.
Pageof 8